105 related articles for article (PubMed ID: 7173793)
1. [The negative list--a false step in the right direction].
Rempen E
Fortschr Med; 1982 Dec; 100(45):2093-5. PubMed ID: 7173793
[No Abstract] [Full Text] [Related]
2. [An end to scurrilous recommendations on the new regulation. What is still allowed on the insurance form?].
Schmidt K
MMW Fortschr Med; 2004 Apr; 146(15):60-2. PubMed ID: 15373023
[No Abstract] [Full Text] [Related]
3. [Bitter pills for insurance patients].
Lüth P
Fortschr Med; 1983 Oct; 101(37):1643-4. PubMed ID: 6642374
[No Abstract] [Full Text] [Related]
4. [Vascular specialists in a campaign against positive list. Threat of deficient care for 4.5 million vascular patients].
Krankenpfl J; 2003; 41(4-6):120. PubMed ID: 12929329
[No Abstract] [Full Text] [Related]
5. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
6. [Regional differentiation among expenditures of general local health insurance for drugs].
Steinhoff F
Offentl Gesundheitswes; 1988 Jun; 50(6):340-2. PubMed ID: 2970038
[No Abstract] [Full Text] [Related]
7. Cost-cutting ideas: prescription drugs.
Fish JL
J Health Care Benefits; 1993; 3(1):10-3. PubMed ID: 10130342
[No Abstract] [Full Text] [Related]
8. PhRMA challenges Maine's novel Rx law.
Tieman J
Mod Healthc; 2000 Aug; 30(34):12-3. PubMed ID: 11185156
[No Abstract] [Full Text] [Related]
9. [Do we need new drugs?].
Deck K
Fortschr Med; 1983 Jan; 101(3):49-50, 87. PubMed ID: 6826129
[No Abstract] [Full Text] [Related]
10. The need for health care reform.
Mossinghoff GJ
Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516
[No Abstract] [Full Text] [Related]
11. Reports confirm high value of step-therapy programs.
Sipkoff M
Manag Care; 2005 Dec; 14(12):6-7. PubMed ID: 16405240
[No Abstract] [Full Text] [Related]
12. [Drug effectiveness in the framework of drug legislation and health insurance law].
Töns H
Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171
[No Abstract] [Full Text] [Related]
13. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals: pharmacy benefit management regulations--2005. End of Year Issue Brief.
Seay M
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-9. PubMed ID: 16710927
[No Abstract] [Full Text] [Related]
15. Pharmaceutical management strategies of industrialized countries.
Brier KL
Formulary; 1995 Oct; 30(10):606-10, 614. PubMed ID: 10151724
[TBL] [Abstract][Full Text] [Related]
16. [Positive list of drugs and osteoporosis].
Krankenpfl J; 2003; 41(4-6):113. PubMed ID: 12929324
[No Abstract] [Full Text] [Related]
17. Monitoring drug compliance can reduce total medical plan costs.
Mandelker J
Bus Health; 1993 May; 11(6):26-7, 31-5. PubMed ID: 10126109
[No Abstract] [Full Text] [Related]
18. Making medicines affordable. A number of states have for years helped older Americans buy needed prescription drugs.
Cauchi R
State Legis; 1999 Dec; 25(10):10-1. PubMed ID: 10848098
[No Abstract] [Full Text] [Related]
19. Specialty pharmaceuticals: developing a management plan.
Willcutts D
Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
[TBL] [Abstract][Full Text] [Related]
20. [The carrot and the stick for physicians and pharmacists. A questionable model for the Bavaria contract on reducing the price of drug therapy].
Girstenbrey W
Fortschr Med; 1984 Jun; 102(24):72-3. PubMed ID: 6469183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
